{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:41:07Z","timestamp":1792392067984,"version":"4.4.0"},"publisher-location":"Berlin, Heidelberg","reference-count":46,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642230554","type":"print"},{"value":"9783642230561","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T00:00:00Z","timestamp":1322784000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-23056-1_9","type":"book-chapter","created":{"date-parts":[[2012,5,7]],"date-time":"2012-05-07T15:14:06Z","timestamp":1336403646000},"page":"179-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Heparin in the Prophylaxis and Treatment of Venous Thromboembolism and Other Thrombotic Diseases"],"prefix":"10.1007","author":[{"given":"Paolo","family":"Gresele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Busti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Paganelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,2]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/bjs.5154","volume":"92","author":"G Agnelli","year":"2005","unstructured":"Agnelli G, Bergqvist D, Cohen AT et al (2005) Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg 92:1212\u20131220","journal-title":"Br J Surg"},{"key":"9_CR2","doi-asserted-by":"crossref","first-page":"67s","DOI":"10.1016\/S0012-3692(08)60110-5","volume":"133","author":"American College of Chest Physicians","year":"2008","unstructured":"American College of Chest Physicians (2008) Antithrombotic and thrombolytic therapy: the American College of Chest Physicians evidenced-based clinical practice guidelines 8th edition. Chest 133:67s\u2013968s","journal-title":"Chest"},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-0038-1647659","volume":"65","author":"DR Anderson","year":"1991","unstructured":"Anderson DR, Ginsberg JS, Burrows R, Brill-Edwards P (1991) Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery. Thromb Haemost 65:248\u2013250","journal-title":"Thromb Haemost"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1203\/00006450-199401000-00016","volume":"35","author":"M Andrew","year":"1994","unstructured":"Andrew M, Marzinotto V, Massicotte P et al (1994) Heparin therapy in pediatric patients: a prospective cohort study. Pediatr Res 35:78\u201383","journal-title":"Pediatr Res"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa060898","volume":"354","author":"EM Antman","year":"2006","unstructured":"Antman EM, Morrow DA, McCabe CH et al (2006) Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 354:1477\u20131488","journal-title":"N Engl J Med"},{"key":"9_CR6","first-page":"633","volume":"46","author":"MT Barrellier","year":"1993","unstructured":"Barrellier MT (1993) Superficial venous thromboses of the legs. Phlebologie 46:633\u2013639","journal-title":"Phlebologie"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00586-003-0538-7","volume":"13","author":"S Brambilla","year":"2004","unstructured":"Brambilla S, Ruosi C, La Maida GA et al (2004) Prevention of venous thromboembolism in spinal surgery. Eur Spine J 13:1\u20138","journal-title":"Eur Spine J"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJM199211193272103","volume":"327","author":"DPM Brandjes","year":"1992","unstructured":"Brandjes DPM, Heijboer H, Buller HR et al (1992) Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 327:1485\u20131489","journal-title":"N Engl J Med"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMe038112","volume":"349","author":"HR Buller","year":"2003","unstructured":"Buller HR, Davidson BL, Decousus H et al (2003) Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 349:1695\u20131702","journal-title":"N Engl J Med"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-140-11-200406010-00007","volume":"140","author":"HR Buller","year":"2004","unstructured":"Buller HR, Davidson BL, Decousus H et al (2004) Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 140:867\u2013873","journal-title":"Ann Intern Med"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","volume":"332","author":"AT Cohen","year":"2006","unstructured":"Cohen AT, Davidson BL, Gallus AS et al (2006) Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 332:325\u2013329","journal-title":"BMJ"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1302\/0301-620X.86B1.14507","volume":"86","author":"JA Cordell-Smith","year":"2004","unstructured":"Cordell-Smith JA, Williams SC, Harper WM et al (2004) Lower limb arthroplasty complicated by deep venous thrombosis: prevalence and subjective outcome. J Bone Joint Surg Br 86:99\u2013101","journal-title":"J Bone Joint Surg Br"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/jama.292.1.45","volume":"292","author":"JJ Ferguson","year":"2004","unstructured":"Ferguson JJ, Califf RM, Antman EM et al (2004) Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 292:45\u201354","journal-title":"JAMA"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(96)91270-2","volume":"347","author":"Fragmin During Instability in Coronary Artery Disease (FRISC) Study Group","year":"1996","unstructured":"Fragmin During Instability in Coronary Artery Disease (FRISC) Study Group (1996) Low-molecular-weight heparin during instability in coronary artery disease. Lancet 347:561\u2013568","journal-title":"Lancet"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(86)91431-5","volume":"2","author":"AS Gallus","year":"1986","unstructured":"Gallus AS, Jackaman J, Tillett J et al (1986) Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet 2:1293\u20131296","journal-title":"Lancet"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1378\/chest.119.1_suppl.132S","volume":"119","author":"WH Geerts","year":"2001","unstructured":"Geerts WH, Heit JA, Clagett GP et al (2001) Prevention of venous thromboembolism. Chest 119:132\u2013175","journal-title":"Chest"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","volume":"126","author":"WH Geerts","year":"2004","unstructured":"Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG (2004) Prevention of venous thromboembolism. Chest 126:338S\u2013400S","journal-title":"Chest"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1001\/archinte.1989.00390100059015","volume":"149","author":"JS Ginsberg","year":"1989","unstructured":"Ginsberg JS, Kowalchuk G, Hirsh J, Brill-Edwards P, Burrows R (1989) Heparin therapy during pregnancy: risks to the fetus and mother. Arch Intern Med 149:2233\u20132236","journal-title":"Arch Intern Med"},{"key":"9_CR19","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1161\/01.CIR.103.24.2994","volume":"103","author":"J Hirsh","year":"2001","unstructured":"Hirsh J, Anand SS, Halperin JL, Fuster V; American Heart Association. (2001) Guide to Anticoagulant Therapy: Heparin. A Statement for Healthcare Professionals From the American Heart Association. Circulation 103:2994\u20133018","journal-title":"Circulation"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1056\/NEJM199005033221802","volume":"322","author":"RD Hull","year":"1990","unstructured":"Hull RD, Raskob GE, Rosenbloom D et al (1990) Heparin for 5\u00a0days as compared with 10\u00a0days in the initial treatment of proximal venous thrombosis. N Engl J Med 322:1260\u20131264","journal-title":"N Engl J Med"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11239-006-7732-5","volume":"22","author":"RD Hull","year":"2006","unstructured":"Hull RD, Schellong SM, Tapson VF et al (2006) Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study. J Thromb Thrombolysis 22:31\u201338","journal-title":"J Thromb Thrombolysis"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1538-7836.2005.01180.x","volume":"3","author":"A Kher","year":"2005","unstructured":"Kher A, Samama MM (2005) Primary and secondary prophylaxis of venous thromboembolism with low-molecular-weight heparins: prolonged thromboprophylaxis, an alternative to vitamin K antagonists. J Thromb Haemost 3:473\u2013481","journal-title":"J Thromb Haemost"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/bjs.1800840605","volume":"84","author":"A Koch","year":"1997","unstructured":"Koch A, Bouges S, Ziegler S et al (1997) Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses. Br J Surg 84:750\u2013759","journal-title":"Br J Surg"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/110241598750005534","volume":"164","author":"I Lausen","year":"1998","unstructured":"Lausen I, Jensen R, Jorgensen LN et al (1998) Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomised controlled study of prolonged thromboprophylaxis. Eur J Surg 164:657\u2013663","journal-title":"Eur J Surg"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1001\/archinte.158.8.873","volume":"158","author":"JR Leclerc","year":"1998","unstructured":"Leclerc JR, Gent M, Hirsh J et al (1998) The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Arch Intern Med 158:873\u2013878","journal-title":"Arch Intern Med"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/153857440303700605","volume":"37","author":"FS Lozano","year":"2003","unstructured":"Lozano FS, Almazan A (2003) Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study. Vasc Endovascular Surg 37:415\u2013420","journal-title":"Vasc Endovascular Surg"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/archinte.162.15.1729","volume":"162","author":"G Meyer","year":"2002","unstructured":"Meyer G, Marjanovic Z, Valcke J et al (2002) Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch Intern Med 162:1729\u20131735","journal-title":"Arch Intern Med"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1046\/j.1440-1754.2003.00139.x","volume":"39","author":"F Newall","year":"2003","unstructured":"Newall F, Barnes C, Ignjatovic V et al (2003) Heparin-induced thrombocytopenia in children. J Paediatr Child Health 39:289\u2013292","journal-title":"J Paediatr Child Health"},{"key":"9_CR29","first-page":"312","volume":"60","author":"A Nicolaides","year":"1973","unstructured":"Nicolaides A, Irving D, Pretzell M et al (1973) The risk of deep-vein thrombosis in surgical patients. Br J Surg 60:312","journal-title":"Br J Surg"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","volume":"276","author":"A Oler","year":"1996","unstructured":"Oler A, Whooley MA, Oler J et al (1996a) Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina: a meta-analysis. JAMA 276:811\u2013815","journal-title":"JAMA"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","volume":"276","author":"A Oler","year":"1996","unstructured":"Oler A, Whooley MA, Oler J, Grady D (1996b) Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. JAMA 276:811\u2013815","journal-title":"JAMA"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/jama.292.1.89","volume":"292","author":"JL Petersen","year":"2004","unstructured":"Petersen JL, Mahaffey KW, Hasselblad V et al (2004) Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: a systematic overview. JAMA 292:89\u201396","journal-title":"JAMA"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2141.2008.07089.x","volume":"141","author":"P Prandoni","year":"2008","unstructured":"Prandoni P, Samama MM (2008) Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients. Br J Haematol 141:587\u2013597","journal-title":"Br J Haematol"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/j.1538-7836.2004.01106.x","volume":"3","author":"P Prandoni","year":"2005","unstructured":"Prandoni P, Tormene D, Pesavento R, Vesalio Investigators Group (2005) High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial. J Thromb Haemost 3:1152\u20131157","journal-title":"J Thromb Haemost"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","volume":"338","author":"PRISM PLUS Study Investigators","year":"1998","unstructured":"PRISM PLUS Study Investigators (1998) Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non\u2013Q-wave myocardial infarction. N Engl J Med 338:1488\u20131497","journal-title":"N Engl J Med"},{"key":"9_CR36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7326\/0003-4819-140-3-200402030-00008","volume":"140","author":"DJ Quinlan","year":"2004","unstructured":"Quinlan DJ, McQuillan A, Eikelboom JW (2004) Low-molecular weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a metaanalysis of randomized, controlled trials. Ann Intern Med 140:175\u2013183","journal-title":"Ann Intern Med"},{"key":"9_CR37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-119-9-199311010-00002","volume":"119","author":"RA Raschke","year":"1993","unstructured":"Raschke RA, Reilly BM, Guidry JR et al (1993) Heparin dosing review. Ann Intern Med 119:104\u2013109","journal-title":"Ann Intern Med"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1046\/j.0306-5251.2001.01517.x","volume":"52","author":"C Richter","year":"2001","unstructured":"Richter C, Sitzmann J, Lang P, Weitzel H, Huch A, Huch R (2001) Excretion of low molecular- weight heparin in human milk. Br J Clin Pharmacol 52:708\u2013710","journal-title":"Br J Clin Pharmacol"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00134-004-2315-4","volume":"30","author":"L Risch","year":"2004","unstructured":"Risch L, Fischer JE, Herklotz R, Huber AR (2004) Heparin-induced thrombocytopenia in paediatrics: clinical characteristics, therapy and outcomes. Intensive Care Med 30:1615\u20131624","journal-title":"Intensive Care Med"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJM199909093411103","volume":"341","author":"MM Samama","year":"1999","unstructured":"Samama MM, Cohen AT, Darmon JY et al (1999) A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 341:793\u2013800","journal-title":"N Engl J Med"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1542\/peds.109.1.e10","volume":"109","author":"M Schmugge","year":"2002","unstructured":"Schmugge M, Risch L, Huber AR et al (2002) Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics 109:E10","journal-title":"Pediatrics"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0002-9343(02)01163-4","volume":"113","author":"V Tagalakis","year":"2002","unstructured":"Tagalakis V, Kahn SR, Libman M, Blostein M (2002) The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med 113:146\u2013151","journal-title":"Am J Med"},{"key":"9_CR43","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/jama.295.13.joc60038","volume":"295","author":"The OASIS-6 Trial Group","year":"2006","unstructured":"The OASIS-6 Trial Group (2006) Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA 295:1519\u20131530","journal-title":"JAMA"},{"key":"9_CR44","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/archinte.163.14.1657","volume":"163","author":"The Superficial Thrombophlebitis Treated by Enoxaparin Study Group","year":"2003","unstructured":"The Superficial Thrombophlebitis Treated by Enoxaparin Study Group (2003) A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Arch Intern Med 163:1657\u20131663","journal-title":"Arch Intern Med"},{"key":"9_CR45","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJMoa055443","volume":"354","author":"S Yusuf","year":"2006","unstructured":"Yusuf S, Mehta SR, Chrolavicius S et al (2006a) Efficacy and safety of fondaparinux compared to enoxaparin in 20,078 patients with acute coronary syndromes without ST segment elevation. The OASIS (Organization to Assess Strategies in Acute Ischemic Syndromes)-5 Investigators. N Engl J Med 354:1464\u20131476","journal-title":"N Engl J Med"},{"key":"9_CR46","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/jama.295.13.joc60038","volume":"295","author":"S Yusuf","year":"2006","unstructured":"Yusuf S, Mehta SR, Chrolavicius S et al (2006b) Effects of fondaparinux on mortality and reinfarction in patients with acute ST-elevation myocardial infarction; the OASIS-6 randomized trial. JAMA 295:1519\u20131530","journal-title":"JAMA"}],"container-title":["Handbook of Experimental Pharmacology","Heparin - A Century of Progress"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-23056-1_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T08:58:05Z","timestamp":1675760285000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-23056-1_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,2]]},"ISBN":["9783642230554","9783642230561"],"references-count":46,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-23056-1_9","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,2]]},"assertion":[{"value":"2 December 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}